X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (13) 13
male (13) 13
oncology (11) 11
prostate cancer (11) 11
aged (10) 10
middle aged (10) 10
cancer (9) 9
chemotherapy (9) 9
metastasis (9) 9
life sciences (8) 8
prostatic neoplasms - pathology (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
disease-free survival (7) 7
hematology, oncology and palliative medicine (7) 7
radiotherapy (7) 7
androgen antagonists - therapeutic use (6) 6
docetaxel (6) 6
neoplasm staging (6) 6
prostatic neoplasms - drug therapy (6) 6
mitoxantrone (5) 5
neoplasm metastasis (5) 5
prostate-specific antigen - blood (5) 5
taxoids - administration & dosage (5) 5
analysis (4) 4
biomarkers, tumor - blood (4) 4
care and treatment (4) 4
estramustine (4) 4
france (4) 4
iii trial (4) 4
prognosis (4) 4
prostate (4) 4
prostatic neoplasms - mortality (4) 4
radical prostatectomy (4) 4
survival analysis (4) 4
urology & nephrology (4) 4
[ sdv ] life sciences [q-bio] (3) 3
[sdv.can]life sciences [q-bio]/cancer (3) 3
abiraterone acetate (3) 3
aged, 80 and over (3) 3
androgen antagonists - administration & dosage (3) 3
androgen-deprivation therapy (3) 3
double-blind (3) 3
follow-up studies (3) 3
kaplan-meier estimate (3) 3
men (3) 3
open-label (3) 3
orchiectomy (3) 3
prostatic neoplasms - blood (3) 3
prostatic neoplasms - radiotherapy (3) 3
prostatic neoplasms - therapy (3) 3
radiation therapy (3) 3
randomized controlled trials as topic (3) 3
risk factors (3) 3
survival (3) 3
survival rate (3) 3
therapy (3) 3
treatment outcome (3) 3
[sdv]life sciences [q-bio] (2) 2
adenocarcinoma (2) 2
adenocarcinoma - blood (2) 2
adenocarcinoma - drug therapy (2) 2
adjuvant (2) 2
adult (2) 2
adverse events (2) 2
androgen deprivation (2) 2
androgen deprivation therapy (2) 2
androgen suppression (2) 2
antigens (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
beam radiation-therapy (2) 2
biochemical recurrence (2) 2
bioengineering (2) 2
biometry (2) 2
bone neoplasms - secondary (2) 2
cancer therapies (2) 2
clinical trials (2) 2
combined modality therapy (2) 2
common terminology criteria (2) 2
confidence intervals (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
enzalutamide (2) 2
estramustine - administration & dosage (2) 2
guidelines (2) 2
irradiation (2) 2
maximum tolerated dose (2) 2
medical prognosis (2) 2
metastatic prostate cancer (2) 2
neoplasm invasiveness - pathology (2) 2
patient outcomes (2) 2
patients (2) 2
plus prednisone (2) 2
prednisone (2) 2
product development (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
prostatectomy (2) 2
quality-of-life (2) 2
suppression (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 747 - 756
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 2, pp. 149 - 158
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 787 - 794
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1442 - 1450
Summary Background Poor prognosis germ-cell tumours are only cured in about half of patients. We aimed to assess whether treatment intensification based on an... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST CYCLE | ETOPOSIDE | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | DENSE CHEMOTHERAPY | HIGH-DOSE CHEMOTHERAPY | COMPLETE-RESPONSE | CANCER | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Oxaliplatin | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Lenograstim | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 70, Issue 2, pp. 256 - 262
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 27, pp. 3097 - 3104
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 1, pp. 85 - 92
Journal Article
European Urology, ISSN 0302-2838, 06/2018, Volume 73, Issue 6, pp. 847 - 855
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. TPS5098 - TPS5098
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 68, Issue 2, pp. 196 - 204
Journal Article
European Urology, ISSN 0302-2838, 05/2018, Volume 73, Issue 5, pp. 696 - 703
Journal Article